December 06, 2018, Thursday
Alembic Pharmaceuticals board also constituted NCD Committee for issue and allotment of NCDs
November 26, 2018, Monday
The approved product is therapeutically equivalent to AstraZeneca Pharmaceuticals' Xylocaine ointment, 5 per cent
October 22, 2018, Monday
International formulations sales grew to Rs 5.87 billion from Rs 2.62 billion in the year-ago period, the company said
June 14, 2018, Thursday
The stock has moved higher by 8% to Rs 530, bouncing back 11% from early morning low of Rs 478 on the BSE.
June 11, 2018, Monday
The stock is locked in upper circuit of 20% at Rs 522 after the company received approval from the USFDA for its ANDA Bupropion ...
November 01, 2017, Wednesday
The mid-cap company has equity capital of Rs 37.70 crore. Face value per share is Rs 2
July 14, 2017, Friday
Vadodara-based Alembic Pharmaceuticals, which inaugurated its oncology oral solids facility at Panelav in the Panchmahals ...
July 11, 2017, Tuesday
The company received USFDA tentative approval for its ANDA for Dabigatran Etexilate Capsules, 150 mg
June 06, 2017, Tuesday
Drug firm Alembic Pharmaceuticals is looking at filing 100 abbreviated new drug applications with the US health regulator over ...
March 10, 2017, Friday
The stock moved higher by 7% to Rs 645 on BSE in intra-day trade.
Copyrights © 2019 Business Standard Private Ltd. All rights reserved.
